AKT1 and metabolic dysfunction-associated steatohepatitis: This was achieved through studying the miRNA paradigm of BM-MSCs that controls PI3K/AKT, hypoxic, VEGF and inflammatory signaling pathways in cardiotoxic state induced by NASH.